The anatomy of a malaria disaster: drug policy choice and mortality in African children (Q36947762)

17 August 2017

1 reference

title

The anatomy of a malaria disaster: drug policy choice and mortality in African children (English)

1 reference

17 August 2017

0 references

Ian M Hastings

1

1 reference

17 August 2017

Eline L Korenromp

series ordinal

2

1 reference

17 August 2017

Peter B Bloland

series ordinal

3

1 reference

17 August 2017

19 September 2007

1 reference

Lancet Infectious Diseases

17 August 2017

1 reference

17 August 2017

7

1 reference

17 August 2017

11

1 reference

17 August 2017

739-748

1 reference

Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Parasitology. A requiem for chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Plasmodium chloroquine resistance and the search for a replacement antimalarial drug

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Impact of chloroquine resistance on malaria mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Are we losing artemisinin combination therapy already?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Coartem (artemether-lumefantrine) in Africa: the beginning of the end?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Modelling a predictable disaster: the rise and spread of drug-resistantmalaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Averting a malaria disaster

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Chloroquine-resistant malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

A single amino acid residue can determine the sensitivity of SERCAs to artemisinins

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Malaria drug-sensitivity testing: new assays, new perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Artemisinin resistance: how can we find it?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Tolerance is the key to understanding antimalarial drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

An immigration-death model to estimate the duration of malaria infection when detectability of the parasite is imperfect

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

The assessment of antimalarial drug efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Usefulness of clinical case-definitions in guiding therapy for African children with malaria or pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

A community perspective on the efficacy of malaria treatment options for children in Lundazi district, Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Malaria and mortality: some epidemiological considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Why do some African children develop severe malaria?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

The problem of malaria and malaria control in pregnancy in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Novel plasmodium falciparum clones and rising clone multiplicities are associated with the increase in malaria morbidity in Ghanaian children during the transition into the high transmission season

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Antifolate antimalarial resistance in southeast Africa: a population-based analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Unstable malaria in Sudan: the influence of the dry season. Clone multiplicity of Plasmodium falciparum infections in individuals exposed to variable levels of disease transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Decline of infant and child mortality rates in rural Senegal over a 37-year period (1963-1999).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Childhood mortality and probable causes of death using verbal autopsy in Niakhar, Senegal, 1989-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

The burden of malaria mortality among African children in the year 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

Response of children with Plasmodium falciparum to chloroquine and development of a national malaria treatment policy in Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970214-1

7 January 2021

10.1016/S1473-3099(07)70214-1

Identifiers

DOI

1 reference

release_vovvf4f63rhlveiypvcmuuezue

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vovvf4f63rhlveiypvcmuuezue

24 November 2022

mapped directly with Wikidata item

1 reference